 Patients fulfilling inclusion and exclusion criteria, and giving informed consent, will be randomised to a treatment arm of 4 units of platelets for every day they have a platelet count 20x103uL, or a control arm with supportive care. Patients will be followed up daily till hospital discharge, and again at day 21. 